Improved mitochondrial function following ischemia and reflow by ATP-MgCl2

Area of Science:

• Biochemistry
• Physiology
• Cell Biology

Background:

• Ischemia-reperfusion injury significantly impacts mitochondrial function.
• Elevated hepatic mitochondrial free fatty acids and calcium levels are hallmarks of ischemia.
• Adenine nucleotide translocase (ANT) activity is crucial for mitochondrial energy production and is often impaired during ischemia.

Purpose of the Study:

• To investigate the effects of infused ATP-MgCl2 on mitochondrial adenine nucleotide translocase (ANT) activity, free fatty acids (FFAs), and Ca2+ levels following hepatic ischemia in rats.
• To compare the efficacy of ATP-MgCl2 with dopamine in mitigating ischemia-induced mitochondrial dysfunction.

Main Methods:

• Hepatic ischemia was induced in rats for 90 minutes, followed by reperfusion.
• Animals received intravenous infusions of saline, ATP-MgCl2, or dopamine immediately upon reflow.
• Hepatic mitochondrial FFAs, Ca2+ levels, and ANT activity were assessed three hours post-reperfusion.

Main Results:

• ATP-MgCl2 infusion significantly reduced elevated mitochondrial FFAs and restored Ca2+ levels post-ischemia.
• While dopamine partially improved depressed ANT activity, ATP-MgCl2 infusion fully restored it.
• ATP-MgCl2 demonstrated a superior effect on mitochondrial function compared to dopamine.

Conclusions:

• Infusion of ATP-MgCl2 following hepatic ischemia effectively improves mitochondrial function.
• The protective effects of ATP-MgCl2 may be attributed to its ability to normalize mitochondrial FFAs and Ca2+ levels and restore ANT activity.
• ATP-MgCl2 represents a promising therapeutic agent for mitigating ischemia-reperfusion injury by enhancing mitochondrial resilience.